Why BELLUS Health (TSX:BLU) Stock Jumped 30% on the TSX Today!

BELLUS (TSX:BLU)(NASDAQ:BLU) stock went stratospheric with the promise of a new drug that could boost fourth-quarter revenue.

| More on:
healthcare pharma

Image source: Getty Images

Shares of BELLUS Health (TSX:BLU)(NASDAQ:BLU) went gangbusters on the TSX today after management announced “positive findings” in a treatment for refractory chronic cough (RCC). Shares of the company jumped 30% by early Tuesday afternoon and continue to climb.

What happened?

The announcement by BELLUS stock management stated that at least one dose of its BLU-5937 — or SOOTHE — would reduce RCC over a 24-hour period. The 240 participants who had more than 25 awake coughs per hour to see whether there would be a reduction.

RCC would be a cough that lasts more than eight weeks, even with treatment for other conditions. It’s expected about nine million people currently suffer from RCC in the United States alone. Right now, there aren’t approved therapies for RCC. With phase two complete, phase three is underway for final results. Management believes it can therefore have data available for fourth quarter of 2021.

So what?

There has been a massive shift in the past few months in the health sector on the TSX today. With a vaccine for COVID-19 available, Big Pharma wants the next big thing. And that could very well be BLU-5937. With no serious side affects and a treatment for both a physically and mentally demanding condition, this could be a major bread winner for BELLUS stock.

Analysts agree. Several analysts upgraded BELLUS stock overnight after the strong results of the treatment. Analysts believe further growth could very well be on the way in the immediate future. There is a limited number of treatments, if any, for patients with RCC. So, this is an untapped market right now that BELLUS stock has discovered — one Motley Fool investors should watch carefully.

Analysts now believe BELLUS stock is a buy, with the average share price rising to $10.70, as of writing. That would be a potential upside at writing of a further 49% over the next year. Even with other companies being first to market, BLU-5937 looks to be the best option with no serious risks.

Now what?

Motley Fool investors seeking the next strong stock have likely already had their eye on the health sector. BELLUS stock not only could be a great buy today, but it offers a cheap share price with this new information. Shares trade at just $7.20 as of writing, up more than $2 overnight! Year to date, those shares are also up 84%, as of writing. That could soar even higher, and the potential of Big Pharma wanting a piece of the action could send this stock stratospheric.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Investing

top TSX stocks to buy
Dividend Stocks

Beat the TSX With This Cash-Gushing Dividend Stock

This dividend stock has been absolutely crushing the TSX 60 and looks like it will continue to do so while…

Read more »

money cash dividends
Stocks for Beginners

Where to Invest $10,000 in April 2024

If you've already created a diversified portfolio and are looking for more options from a windfall, here is where I…

Read more »

data analyze research
Investing

The Ultimate TSX Stock to Buy With $1,000 Right Now

Brookfield Asset Management (TSX:BAM) is one of the best Canadian stocks to buy for those looking to put capital to…

Read more »

young woman celebrating a victory while working with mobile phone in the office
Dividend Stocks

3 CRA Benefits Most Canadians Can Grab in 2024

You can save on taxes by claiming the dividend tax credit on Fortis Inc (TSX:FTS) shares.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »